2021
DOI: 10.1681/asn.2020111579
|View full text |Cite
|
Sign up to set email alerts
|

Circulating Soluble Fms-like Tyrosine Kinase in Renal Diseases Other than Preeclampsia

Abstract: Soluble Fms-like tyrosine kinase (sFlt-1/sVEGFR1) is a natural occurring antagonist of vascular endothelial growth factor (VEGF). Despite being a secreted, soluble protein lacking cytoplasmic and transmembrane domains, sFlt-1 can act locally and be protective against excessive microenvironmental VEGF concentration, or exert autocrine functions independently of VEGF. Circulating sFlt-1 may indiscriminately affect endothelial function and the microvasculature on distant target organs. The clinical significance o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
12
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 81 publications
0
12
0
Order By: Relevance
“…Higher sFlt-1 levels were also independently associated with incident heart failure or cardiovascular mortality in heart failure patients [23]. Moreover, elevated circulating sFlt-1 levels can cause glomerular endothelial cell damage in a series of kidney diseases, as the kidney possesses a highly organized vasculature and specialized endothelial cells [24]. Elevated sFlt-1 in MHT may suggest its role in helping diagnosis and evaluation of the severity of hypertensive organ damage.…”
Section: Discussionmentioning
confidence: 98%
“…Higher sFlt-1 levels were also independently associated with incident heart failure or cardiovascular mortality in heart failure patients [23]. Moreover, elevated circulating sFlt-1 levels can cause glomerular endothelial cell damage in a series of kidney diseases, as the kidney possesses a highly organized vasculature and specialized endothelial cells [24]. Elevated sFlt-1 in MHT may suggest its role in helping diagnosis and evaluation of the severity of hypertensive organ damage.…”
Section: Discussionmentioning
confidence: 98%
“…(C) Tissue of human preeclampsia decidual vasculopathy with fibrinoid necrosis are shown. (D) Inadequate remodelling by the cytotrophoblast invasion of spiral arteries reducing blood flow causing placental ischemia (PLA‐ISC) 12 , 13 promoting the secretion of sFlt‐1, 16 VEGF 20 and PIGF. 18 This environment promotes deregulation between e Hsp‐60, e Hsp‐70 and e Hsp‐27 (Figure 1 ).…”
Section: Discussionmentioning
confidence: 99%
“…14 During the second stage of this abnormal placentation, there is a proangiogenic and antiangiogenic imbalance, 15,16 including soluble Fms-like tyrosine kinase-1 (sFlt-1), vascular endothelial growth factor (VEGF) and placental growth factor (PIGF). [17][18][19][20] The decrease in these proteins in plasma is correlated with the severity of PE and with the development of adverse pregnancy outcomes [21][22][23] attributed to an increase in pro-inflammatory cytokines. 24,25 These serum markers and their indices (sFlt-1/PIGF ratio) are only used in prediction models later on in pregnancy.…”
Section: Introductionmentioning
confidence: 99%
“…Excess sFlt-1 is associated with endothelial dysfunction in heart failure, sepsis, preeclampsia, chronic kidney disease, kidney transplantation, and many other diseases, including COVID-19 infection [ 13 , 14 , 15 , 16 ]. Interestingly, the damage to the eGC was suggested to be the leading cause of endothelial dysfunction in various cardiovascular, inflammatory, and kidney diseases [ 12 , 17 , 18 , 19 ].…”
Section: Introductionmentioning
confidence: 99%